000			02009 a2200613 4500
005			20250516085452.0
264		0	_c20120815
008			201208s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2012-02-413161 _2doi
040			_aNLM _beng _cNLM
100	1		_aDispenzieri, Angela
245	0	0	_aActivity of pomalidomide in patients with immunoglobulin light-chain amyloidosis. _h[electronic resource]
260			_bBlood _cJun 2012
300			_a5397-404 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmyloidosis _xdrug therapy
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aDexamethasone _xadverse effects
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Therapy, Combination _xadverse effects
650	0	4	_aFemale
650	0	4	_aHematologic Tests
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Light Chains _xmetabolism
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPlasma Cells _xdrug effects
650	0	4	_aThalidomide _xadverse effects
700	1		_aBuadi, Francis
700	1		_aLaumann, Kristina
700	1		_aLaPlant, Betsy
700	1		_aHayman, Suzanne R
700	1		_aKumar, Shaji K
700	1		_aDingli, David
700	1		_aZeldenrust, Steven R
700	1		_aMikhael, Joseph R
700	1		_aHall, Robert
700	1		_aRajkumar, S Vincent
700	1		_aReeder, Craig
700	1		_aFonseca, Rafael
700	1		_aBergsagel, P Lief
700	1		_aStewart, A Keith
700	1		_aRoy, Vivek
700	1		_aWitzig, Thomas E
700	1		_aLust, John A
700	1		_aRussell, Stephen J
700	1		_aGertz, Morie A
700	1		_aLacy, Martha Q
773	0		_tBlood _gvol. 119 _gno. 23 _gp. 5397-404
856	4	0	_uhttps://doi.org/10.1182/blood-2012-02-413161 _zAvailable from publisher's website
999			_c21694976 _d21694976